APEIRON BIOLOGICS AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 13242
 
  
 
C07K PEPTIDES 3133
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9840566 Preparations and methods for treating a GD2 positive cancerNov 21, 14Dec 12, 17[A61K, C07K]
9777068 Method for treating a GD2 positive cancerJul 31, 12Oct 03, 17[A61K, C07K]
9757433 Modified ACE2 polypeptidesJan 13, 14Sep 12, 17[A61K, C12N]
9561263 Treatment of inflammatory illnesses with ACE2Dec 18, 08Feb 07, 17[A61K]
9186373 SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancerDec 27, 11Nov 17, 15[C07H, A61K, C12N]
8946162 Treatment of tumorsApr 07, 09Feb 03, 15[A61K]
8809288 Method for increasing immunoreactivityDec 10, 08Aug 19, 14[A61K, C07H]
8802084 ACE2 activation for treatment of heart, lung and kidney disease and hypertensionMay 31, 12Aug 12, 14[A61K]
8586319 Recombinant ACE2 polypeptide dimerJun 12, 08Nov 19, 13[A61K]
8211426 ACE2 activation for treatment of heart, lung and kidney disease and hypertensionJul 06, 10Jul 03, 12[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0313,931 SIRNA AGAINST CBL-B AND OPTIONALLY IL-2 AND IL-12 FOR USE IN THE TREATMENT OF CANCERAbandonedJul 16, 15Nov 05, 15[A61K]
2014/0099,297 ACE2 POLYPEPTIDEAbandonedSep 13, 13Apr 10, 14[A61K]
2012/0040,864 Method for Determining the Cbl-b ExpressionAbandonedApr 14, 10Feb 16, 12[G01N, C40B, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.